Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.88 is 42% above its 5-year average of -1.52, near the high end of its 5-year range (-4.59–-0.68).
As of the fiscal period ended Sunday, May 31, 2026. 2.92% below its 12-month average of -0.85.
Reported quarterly EPS; no daily interpolation. Q4 FY2026 (2026-05-31): -0.28.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T12:45:24.406Z. Historical observations retain their original dates. Historical series through 2024-01-08.
EARNINGS PER SHARE (EPS)
-0.88
EARNINGS PER SHARE (EPS) AVG TTM
-0.85
EARNINGS PER SHARE (EPS) AVG 3Y
-1.91
EARNINGS PER SHARE (EPS) AVG 5Y
-1.52
EARNINGS PER SHARE (EPS) AVG 10Y
-1.17
EARNINGS PER SHARE (EPS) AVG 15Y
-0.42
EARNINGS PER SHARE (EPS) AVG 20Y
-0.12
CURRENT VS TTM AVG
-2.92%
CURRENT VS 3Y AVG
+53.87%
CURRENT VS 5Y AVG
+42.17%
CURRENT VS 10Y AVG
+24.61%
CURRENT VS 15Y AVG
-111.49%
CURRENT VS 20Y AVG
-611.73%
AngioDynamics, Inc.
Market Cap
$642.31M
Earnings Per Share (EPS)
-0.88
TTM Avg
-0.85
3Y Avg
-1.91
5Y Avg
-1.52
Market Cap
$643.37M
Earnings Per Share (EPS)
-1.78
TTM Avg
-1.75
3Y Avg
-1.85
5Y Avg
-1.69
Market Cap
$637.59M
Earnings Per Share (EPS)
-2.82
TTM Avg
-1.69
3Y Avg
-1.06
5Y Avg
3.72
Market Cap
$632.76M
Earnings Per Share (EPS)
-0.83
TTM Avg
-1.21
3Y Avg
-1.36
5Y Avg
-1.94
Market Cap
$675.41M
Earnings Per Share (EPS)
-2.72
TTM Avg
-2.70
3Y Avg
-2.77
5Y Avg
-2.61
Market Cap
$688.14M
Earnings Per Share (EPS)
-1.16
TTM Avg
-1.18
3Y Avg
-1.68
5Y Avg
-2.29
Market Cap
$596.36M
Earnings Per Share (EPS)
-0.58
TTM Avg
-1.12
3Y Avg
-1.21
5Y Avg
-1.27
Market Cap
$698.60M
Earnings Per Share (EPS)
-141.65
TTM Avg
-20.37
3Y Avg
-24.20
5Y Avg
-22.76
Market Cap
$579.88M
Earnings Per Share (EPS)
N/A
TTM Avg
-1.57
3Y Avg
-1.57
5Y Avg
-1.57
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AngioDynamics, Inc. (ANGO) | $642.31M | -0.88 | -0.85 | -1.91 | -1.52 |
| Aura Biosciences, Inc. (AURA)vs › | $643.37M | -1.78 | -1.75 | -1.85 | -1.69 |
| Fulgent Genetics, Inc. (FLGT)vs › | $637.59M | -2.82 | -1.69 | -1.06 | 3.72 |
| Climb Bio, Inc. (CLYM)vs › | $632.76M | -0.83 | -1.21 | -1.36 | -1.94 |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $675.41M | -2.72 | -2.70 | -2.77 | -2.61 |
| Annexon, Inc. (ANNX)vs › | $688.14M | -1.16 | -1.18 | -1.68 | -2.29 |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $596.36M | -0.58 | -1.12 | -1.21 | -1.27 |
| Faeth Therapeutics, Inc. (FTH)vs › | $698.60M | -141.65 | -20.37 | -24.20 | -22.76 |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $579.88M | N/A | -1.57 | -1.57 | -1.57 |
| Helus Pharma Inc. (HELP)vs › | $707.86M | -5.51 | -4.06 | -4.55 | -6.70 |
Trailing EPS (TTM)
$-0.88
Forward EPS (Est.)
$-0.27
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2026-05-31 | -0.88 |
| 2025-05-31 | -0.83 |
| 2024-05-31 | -4.59 |
| 2023-05-31 | -1.33 |
| 2022-05-31 | -0.68 |
| 2021-05-31 | -0.82 |
| 2020-05-31 | -4.37 |
| 2019-05-31 | 1.64 |
| 2018-05-31 | 0.44 |
| 2017-05-31 | -0.19 |
| 2016-05-31 | -1.23 |
| 2015-05-31 | -0.09 |
| 2014-05-31 | 0.09 |
| 2013-05-31 | -0.02 |
| 2012-05-31 | -0.20 |
| 2011-05-31 | 0.33 |
| 2010-05-31 | 0.50 |
| 2009-05-31 | 0.41 |
| 2008-05-31 | 0.45 |
| 2007-05-31 | -0.49 |
| 2006-05-31 | 0.55 |
| 2005-05-31 | 0.39 |
| 2004-05-31 | 0.34 |
| 2003-05-31 | 0.13 |
| 2002-05-31 | 0.11 |
| 2001-05-31 | 0.04 |
(FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown Quote observation: 2026-10-06T12:45:24.406Z. Historical observations retain their original dates. Historical series through 2011-08-12.
